about
Indigenous Plasmodium ovale malaria in BangladeshThe challenges of introducing routine G6PD testing into radical cure: a workshop report.Evaluation of the Widal tube agglutination test for the diagnosis of typhoid fever among children admitted to a rural hdospital in Tanzania and a comparison with previous studiesCharacterization of a novel class of antimalarials and its applicability to plasmodial target identification.Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialAssessment and comparative analysis of a rapid diagnostic test (Tubex®) for the diagnosis of typhoid fever among hospitalized children in rural TanzaniaReplacing paper data collection forms with electronic data entry in the field: findings from a study of community-acquired bloodstream infections in Pemba, Zanzibar.The burden of invasive bacterial infections in Pemba, Zanzibar.Evaluation of a rapid dipstick (Crystal VC) for the diagnosis of cholera in Zanzibar and a comparison with previous studies.Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy.Cost of illness due to typhoid Fever in pemba, zanzibar, East Africa.Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.Clinical and epidemiological features of typhoid fever in Pemba, Zanzibar: assessment of the performance of the WHO case definitions.Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central VietnamA systematic review and meta-analysis of the performance of two point of care typhoid fever tests, Tubex TF and Typhidot, in endemic countries.Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trialVariation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern EthiopiaChloroquine efficacy for Plasmodium vivax malaria treatment in southern EthiopiaPerformance and user acceptance of the Bhutan febrile and malaria information system: report from a pilot studyUtilization and accessibility of healthcare on Pemba Island, Tanzania: implications for health outcomes and disease surveillance for typhoid fever.Antibiotic prescribing in DR Congo: a knowledge, attitude and practice survey among medical doctors and studentsMolecular characterization of high-level-cholera-toxin-producing El Tor variant Vibrio cholerae strains in the Zanzibar Archipelago of Tanzania.Antimalarial activity of tigecycline, a novel glycylcycline antibiotic.High prevalence of asymptomatic malaria in south-eastern BangladeshEvidence of a major reservoir of non-malarial febrile diseases in malaria-endemic regions of Bangladesh.Desirability for a typhoid fever vaccine among rural residents, Pemba Island, Tanzania.Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial.In vitro interaction of dihydroartemisin and lumefantrine in clinical field isolates from Bangladesh.In vitro activity of artemisinin alone and in combination with retinol against Plasmodium falciparum.Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, the United Republic of Tanzania.Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.Genotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh.[In vitro antimalarial drug resistance in Southeastern Bangladesh].Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh.Correction: Clinical and Epidemiological Features of Typhoid Fever in Pemba, Zanzibar: Assessment of the Performance of the WHO Case Definitions.[In vitro interaction studies of azithromycin and dihydroartemisinin in Plasmodium falciparum isolates from Bangladesh].Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.The assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan AfricaThe efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
P50
Q24600053-7E8FCB02-A14F-4814-BB5D-6E575C5DC998Q30666192-1FC5F4B0-F2D3-4877-9F52-E45653F2B43FQ30984758-0E7E2B3A-50CF-451B-97D3-1D905A0407C9Q33305231-3EE8866F-648A-4610-BC42-5CA0FC9A2CF9Q33693625-DB6A6A94-0B62-4880-8188-8F94B0FD027DQ33910444-4F54BD51-AAB2-4A65-9709-32EC28B9F436Q34165617-41BA20D5-2F82-4132-ABDB-C84EE1F5F370Q34169960-FFEA4BBE-83DB-417D-9DEB-4F0AA2A3F029Q34290950-00AD02A7-D3B4-4341-9B1F-992A826F2DB7Q34359766-8A142B45-CB72-41F0-8C22-9EE9C78D4C03Q34458464-EBCBC741-4DCF-420F-BDF9-888739BFA34FQ34517634-D27CD210-8CF8-46A1-957D-35E44B09A802Q34532346-9DB1D300-63E2-431A-AA83-E7517536BB56Q34597617-16017624-DD70-4A51-9324-C2FC6216C6FEQ35072486-D734C725-20A4-4441-9924-98EBDF848767Q35078624-DFF53950-EC6F-4602-BAFD-F533BA512B43Q35807931-98F31945-7984-459B-BB98-B1A5797EF100Q36402050-AA05EC1D-CC0A-45A0-90E2-F50EB1A89660Q36517526-6B4D3F1D-43B2-4E25-AB4B-BC4C75EA50BBQ36522998-25287D0D-0C52-4075-9DF1-82E0D26E5941Q36618523-9A5DDC5B-0673-4E3A-9F23-A7471AEEE016Q36667628-866C45D2-3D65-42B7-ADF2-78171E8766BDQ37333066-6F34F87C-F4C1-4BEB-8E87-8C13EC63E22FQ37497027-7F758E34-D77F-456A-8B41-748D02FD1F5FQ37573039-90A5537A-BF05-472B-B85E-B14BA1D8FF5AQ38408278-175D6612-9A45-4EF0-BAEC-7A40366626EBQ39081800-5FD01828-9981-48C3-8EA8-98D4D149756FQ39523306-AE68B0F2-6678-4DAE-A053-536BCCD1335DQ39523314-3750115B-961A-4D32-B49C-8D0BF0DBD7E1Q39523321-61FC66E4-CAE7-4C4C-AC89-9AEB65676D96Q39941003-0A8BAF75-6D80-424D-BF2A-1ACC0695FE97Q40061329-11B3D6FF-DEC1-4D62-AECA-6EB868668AFDQ41927676-E585555D-E848-467E-A66B-D54FF24666E1Q41944085-4498443C-842E-4FE3-88D8-52EBB909070BQ41944380-7F52AC4C-2E02-4678-8444-FA4BE4918348Q45790832-35C6AD60-0C98-48B2-926B-C8FEFC0F4E42Q46911464-4337FCC8-97F1-454C-9B5E-2DBA9BD17B62Q55493552-38E40175-FBF5-4966-88BF-780BE3F2DFB1Q60915761-6605F58A-586B-44D7-983C-E93274C992FCQ90483132-38E9AB24-F1F1-4721-BE32-98AEE19E9E82
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kamala Thriemer
@ast
Kamala Thriemer
@en
Kamala Thriemer
@es
Kamala Thriemer
@nl
Kamala Thriemer
@sl
type
label
Kamala Thriemer
@ast
Kamala Thriemer
@en
Kamala Thriemer
@es
Kamala Thriemer
@nl
Kamala Thriemer
@sl
altLabel
Kamala Ley-Thriemer
@en
prefLabel
Kamala Thriemer
@ast
Kamala Thriemer
@en
Kamala Thriemer
@es
Kamala Thriemer
@nl
Kamala Thriemer
@sl
P106
P21
P31
P496
0000-0001-7536-7497